Elvitegravir cobicistat emtricitabine tenofovir: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) Created page with "__NOTOC__" |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Elvitegravir cobicistat emtricitabine tenofovir}} | |||
{{CMG}}; {{AE}} {{MM}} | |||
==Overview== | |||
==Category== | |||
Antiretroviral | |||
==US Brand Names== | |||
STRIBILD<sup>®</sup> | |||
==FDA Package Insert== | |||
''' [[Elvitegravir cobicistat emtricitabine tenofovir description|Description]]''' | |||
'''| [[Elvitegravir cobicistat emtricitabine tenofovir clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Elvitegravir cobicistat emtricitabine tenofovir microbiology|Microbiology]]''' | |||
'''| [[Elvitegravir cobicistat emtricitabine tenofovir indications and usage|Indications and Usage]]''' | |||
'''| [[Elvitegravir cobicistat emtricitabine tenofovir contraindications|Contraindications]]''' | |||
'''| [[Elvitegravir cobicistat emtricitabine tenofovir warnings and precautions|Warnings and Precautions]]''' | |||
'''| [[Elvitegravir cobicistat emtricitabine tenofovir adverse reactions|Adverse Reactions]]''' | |||
'''| [[Elvitegravir cobicistat emtricitabine tenofovir overdosage|Overdosage]]''' | |||
'''| [[Elvitegravir cobicistat emtricitabine tenofovir dosage and administration|Dosage and Administration]]''' | |||
'''| [[Elvitegravir cobicistat emtricitabine tenofovir how supplied|How Supplied]]''' | |||
'''| [[Elvitegravir cobicistat emtricitabine tenofovir labels and packages|Labels and Packages]]''' | |||
==Mechanism of Action== | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Antibiotics]] | |||
[[Category:Wikinfect]] |
Revision as of 05:23, 10 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Category
Antiretroviral
US Brand Names
STRIBILD®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Dosage and Administration | How Supplied | Labels and Packages